What to expect when you take Carbidopa and levodopa and have Insomnia?

Do you take Carbidopa and levodopa and have Insomnia? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jul, 03, 2018

2,558 reports have been studied.


Females aged 50 to 59 :

1,298 related reports were analyzed:

Most common symptoms:

Depression
  • 5.56% for females aged 50 (±5) who take Carbidopa and levodopa
Dizziness
  • 7.26% for females aged 50 (±5) who take Carbidopa and levodopa
Drug ineffective
  • 5.73% for females aged 50 (±5) who take Carbidopa and levodopa
Dyskinesia (abnormality or impairment of voluntary movement)
  • 6.29% for females aged 50 (±5) who take Carbidopa and levodopa
Dyspnea (difficult or laboured breathing)
  • 5.56% for females aged 50 (±5) who take Carbidopa and levodopa
Fall
  • 6.77% for females aged 50 (±5) who take Carbidopa and levodopa
Fatigue (feeling of tiredness)
  • 5.73% for females aged 50 (±5) who take Carbidopa and levodopa
Nausea (feeling of having an urge to vomit)
  • 6.85% for females aged 50 (±5) who take Carbidopa and levodopa
Pain
  • 5.65% for females aged 50 (±5) who take Carbidopa and levodopa
Parkinson's disease
  • 5.89% for females aged 50 (±5) who take Carbidopa and levodopa
Stress and anxiety
  • 6.13% for females aged 50 (±5) who take Carbidopa and levodopa

Most common co-existing conditions:

Bipolar disorder (mood disorder)
  • 10.34% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  • 15.52% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
High blood cholesterol
  • 10.34% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Related Tests
High blood pressure
  • 5.73% for females aged 50 (±5) who take Carbidopa and levodopa
Multiple myeloma (cancer of the plasma cells)
  • 17.24% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 5.24% for females aged 50 (±5) who take Carbidopa and levodopa
Muscle spasms (muscle contraction)
  • 15.52% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Neuropathy peripheral (surface nerve damage)
  • 10.34% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Sleep disorder
  • 12.07% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Thyroid diseases
  • 12.07% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Type 2 diabetes
  • 12.07% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Upper respiratory tract infection
  • 15.52% for females aged 50 (±5) who take Carbidopa and levodopa and have insomnia
back to top

Males aged 50 to 59 :

1,260 related reports were analyzed:

Most common symptoms:

Dyskinesia (abnormality or impairment of voluntary movement)
  • 5.29% for males aged 50 (±5) who take Carbidopa and levodopa
Fall
  • 5.54% for males aged 50 (±5) who take Carbidopa and levodopa
Parkinson's disease
  • 6.94% for males aged 50 (±5) who take Carbidopa and levodopa
Pathological gambling
  • 5.62% for males aged 50 (±5) who take Carbidopa and levodopa
Tremor (trembling or shaking movements in one or more parts of your body)
  • 5.79% for males aged 50 (±5) who take Carbidopa and levodopa

Most common co-existing conditions:

Dyskinesia (abnormality or impairment of voluntary movement)
  • 12.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Gait disturbance
  • 12.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Initial insomnia (feeling of inadequate or poor-quality sleep)
  • 10.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Motor dysfunction (dysfunction of a muscle, nerve, or centre that effects or produces motion)
  • 12.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Muscle rigidity (muscle stiffness)
  • 10.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Routine health maintenance
  • 10.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
Thrombosis (formation of a blood clot inside a blood vessel)
  • 12.0% for males aged 50 (±5) who take Carbidopa and levodopa and have insomnia
back to top

Related studies

carbidopa and levodopa

Carbidopa and levodopa has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. (latest outcomes from Carbidopa and levodopa 2,978 users)

insomnia

Insomnia (sleeplessness) has been reported by people with depression, pain, multiple sclerosis, insomnia, high blood pressure (latest reports from 230,103 Insomnia patients).

Carbidopa and levodopa and Insomnia

Related publications that referenced our studies


Analysis tools (to study 526 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Carbidopa and levodopa, Insomnia

Recent updates

General studies
Active Support Groups
Recent Predictions

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.